UNSPSC 51381900: Nonsteroidal anti inflammatory azoles

Nonsteroidal anti inflammatory drugs made from five membered rings containing a nitrogen atom, called AZOLES.

UNSPSC 51381900 Nonsteroidal anti-inflammatory azoles is a Class code that encompasses pharmaceutical procurement by state and local health agencies, though the recent opportunities tagged under it diverge significantly from the code's nominal scope—covering naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals rather than nonsteroidal anti-inflammatory compounds specifically. State and local health departments, cooperative purchasing alliances, and county health systems issue under this code. The work ranges from emergency-response pharmaceuticals and opioid-antagonist procurement to broader pharmacy benefit program redesign and generic medication supply agreements through authorized wholesaler networks.

Geographic activity centers on Florida, Texas, and Minnesota in recent solicitations. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: date discrepancy in source). The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic pharmaceuticals and OTC products with a March 26, 2026 response deadline, requiring vendor compliance with cGMP, Drug Supply Chain Security Act certification, and relationships with AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers. Contracts under MMCAP extend to Oregon and other participating jurisdictions. The code shows active state health agency engagement but limited recent commodity-level specificity—bidders should track cooperative purchasing vehicle RFPs and health department direct procurements as the primary opportunity stream.